Stella Pharma Corporation (TYO:4888)
Japan · Delayed Price · Currency is JPY 411.00
+9.00 (2.24%)
Sep 16, 2026, 2:15 PM JST
Stella Pharma Market Cap
Stella Pharma has a market cap or net worth of 14.89 billion as of September 15, 2026. Its market cap has increased by 20.84% in one year.
Market Cap
14.89B
Enterprise Value
11.98B
Revenue
323.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
411.00
ChartMarket Cap Chart
Since April 22, 2021, Stella Pharma's market cap has decreased from 23.73B to 14.89B, a decrease of -37.26%. That is a compound annual growth rate of -8.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 14.89B | 115.49% |
| Dec 30, 2025 | 6.91B | -62.20% |
| Dec 30, 2024 | 18.28B | 105.37% |
| Dec 29, 2023 | 8.90B | -22.42% |
| Dec 30, 2022 | 11.47B | -56.48% |
| Dec 30, 2021 | 26.35B | 11.06% |
| Apr 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RaQualia Pharma | 14.79B |
| AnGes | 14.36B |
| ReproCELL | 14.22B |
| CanBas | 14.05B |
| StemRIM | 11.28B |
| Kubota Pharmaceutical Holdings | 10.86B |
| Immuno-Biological Laboratories | 10.82B |
| K Pharma,Inc. | 9.45B |